A similar contrast was observed in a study where TGF-β inhibition enhanced the efficacy of checkpoint blockade in the MC38 tumor model but was unable to do so in a model for murine pancreatic cancer (23). The gene discussed is TGFB1; the disease is familial pancreatic carcinoma.